HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana (Q40800156)

23 September 2017

HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana (English)

1 reference

23 September 2017

0 references

12

Max Essex

1 reference

23 September 2017

11

Ibou Thior

1 reference

23 September 2017

10

Richard Marlink

1 reference

23 September 2017

6

Lesego Gabaitiri

1 reference

23 September 2017

8

Simane Gaseitsiwe

1 reference

23 September 2017

2

Vladimir Novitsky

1 reference

23 September 2017

9

Thumbi Ndungú

1 reference

23 September 2017

Hermann Bussmann

1

1 reference

23 September 2017

William Wester

3

1 reference

23 September 2017

Trevor Peter

4

1 reference

23 September 2017

Kereng Masupu

5

1 reference

23 September 2017

Soyeon Kim

7

1 reference

23 September 2017

1 January 2005

1 reference

Antiviral Chemistry & Chemotherapy

23 September 2017

1 reference

23 September 2017

16

1 reference

23 September 2017

2

1 reference

23 September 2017

103-115

1 reference

Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy

23 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

HIV-1 drug resistance in newly infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Prevalence of antiretroviral resistance in a South London cohort of treatment-naive HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Primary antiretroviral resistance in newly diagnosed patients with established heterosexually acquired HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

So what infected the chimpanzee?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Antiretroviral-drug resistance among patients recently infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

HIV type 1 A/J recombinant with a pronounced pol gene mosaicism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Genotypic testing for human immunodeficiency virus type 1 drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600203

10.1177/095632020501600203

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference